Literature DB >> 15385198

Branch retinal arterial occlusion associated with toxoplasmic chorioretinitis.

Cem Küçükerdönmez1, Gürsel Yilmaz, Yonca A Akova.   

Abstract

BACKGROUND: Ocular toxoplasmosis can cause a variety of retinal vascular changes including branch retinal arterial occlusion, which is a rare complication of the disease. PATIENT AND METHODS: We report a case of toxoplasmic chorioretinitis in a pregnant woman, who developed branch retinal arterial obstruction adjacent to the active chorioretinitis lesion.
RESULTS: The patient received an appropriate steroid and antibiotic treatment and the retinitis lesion resolved over a six-week period. At two months after diagnosis, visual acuity in her right eye was 20/30 and there was a hyperpigmented scar at the site where active retinitis had been observed.
CONCLUSION: Especially in young patients with branch retinal vascular occlusion associated with posterior uveitis, the diagnosis of ocular toxoplasmosis should be kept in mind and serologic test results should be obtained.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15385198     DOI: 10.1080/092739490500246

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  4 in total

1.  Atypical toxoplasmic retinochoroiditis.

Authors:  Sofia Theodoropoulou; Conrad Schmoll; Kate Templeton; Baljean Dhillon
Journal:  BMJ Case Rep       Date:  2012-05-30

2.  Branch Retinal Artery Occlusion Associated with Toxoplasma Retinitis.

Authors:  Ashley E Neiweem; Denis Jusufbegovic
Journal:  Korean J Ophthalmol       Date:  2020-08

3.  Branch retinal artery occlusion associated with posterior uveitis.

Authors:  Rim Kahloun; Samah Mbarek; Imen Khairallah-Ksiaa; Bechir Jelliti; Salim Ben Yahia; Moncef Khairallah
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-21

4.  Branch retinal artery occlusion caused by toxoplasmosis in an adolescent.

Authors:  Elizabeth Chiang; Debra A Goldstein; Michael J Shapiro; Marilyn B Mets
Journal:  Case Rep Ophthalmol       Date:  2012-10-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.